scholarly journals A randomized controlled trial of low carbohydrate and low fat/high fiber diets for weight loss.

1986 ◽  
Vol 76 (11) ◽  
pp. 1293-1296 ◽  
Author(s):  
J A Baron ◽  
A Schori ◽  
B Crow ◽  
R Carter ◽  
J I Mann
2021 ◽  
pp. 6-8
Author(s):  
Maitri Hathi ◽  
Sudesh Kumar ◽  
Himanshu Nagar

BACKGROUND: Ketogenic diet is now in trend. But very less researches were conducted in India to check signicant effects on weight loss of Ketogenic Diet among overweight/obese adults compared to calorie restricted Low Fat diet. OBJECTIVE:To compare the effect of Very Low Carbohydrate Ketogenic (VLCK) diet and energy restricted Low-Fat (LF) diets on weight loss in overweight/obese healthy adults. Design: An interventional randomized controlled trial of 6 months was initiated. PARTICIPANTS: 113 overweight/obese adults with a body mass index of 25 kg/m2 or greater; with no abnormalities and more than 20 years of age. INTERVENTION: Among 113 overweight/obese adults, we conducted a six-month randomized controlled trial of two sets of dietary advice, each providing approximately 12,00-1500 calories per day but differing in protein, ber, fat and carbohydrate content. RESULTS: We found that dieters given VLCK advice tended to lose more weight than those given a LF diet. CONCLUSION: For short period of time VLCK diet is more effective than conventional LF diet for weight loss. But for long term effects further studies are required.


2020 ◽  
Author(s):  
Chio Yokose ◽  
Natalie McCormick ◽  
Sharan K. Rai ◽  
Na Lu ◽  
Gary Curhan ◽  
...  

Objectives: <a>Weight loss diets may reduce serum urate (SU) by lowering insulin resistance while providing cardiometabolic benefits, something urate-lowering drugs have not shown in trials. </a>We aim to examine the effects of weight loss diets on SU and cardiometabolic risk factors. <p>Research Design and Methods: Secondary study of the Dietary Intervention Randomized Controlled Trial (DIRECT) using stored samples from 235 participants with moderate obesity randomly assigned to low-fat, restricted-calorie (n=85), Mediterranean, restricted-calorie (n=76), or low-carbohydrate, non-restricted-calorie (n=74) diets. We examined SU changes at 6- and 24-months overall, and among those with hyperuricemia (SU³416 μmol/L), a relevant subgroup at risk for gout.</p> <p>Results: Among all participants, average SU decreases were 48 μmol/L at 6-months and 18 μmol/L at 24-months, with no differences between diets (p>0.05). Body weight, HDL-C, total cholesterol to HDL-C ratio, triglycerides, and insulin concentrations also improved in all three groups (p<0.05 at 6 months). Adjusting for covariates, changes in weight and fasting plasma insulin concentrations remained associated with SU changes (p<0.05). SU reductions among those with hyperuricemia were 113, 119, and 143 μmol/L at 6 months for low-fat, Mediterranean, and low-carbohydrate diets (all p for within-group comparison <0.001; p>0.05 for between-group comparisons), and 65, 77, and 83 μmol/L, respectively, at 24-months (all p for within-group comparison <0.01; p>0.05 for between-group comparisons).</p> <a>Conclusions</a>: <a>Non-purine-focused weight loss diets may simultaneously improve SU and cardiovascular risk factors, likely mediated by reducing adiposity and insulin resistance. </a>These dietary options could provide personalized pathways to suit patient comorbidity and preferences for adherence.


2020 ◽  
Author(s):  
Chio Yokose ◽  
Natalie McCormick ◽  
Sharan K. Rai ◽  
Na Lu ◽  
Gary Curhan ◽  
...  

Objectives: <a>Weight loss diets may reduce serum urate (SU) by lowering insulin resistance while providing cardiometabolic benefits, something urate-lowering drugs have not shown in trials. </a>We aim to examine the effects of weight loss diets on SU and cardiometabolic risk factors. <p>Research Design and Methods: Secondary study of the Dietary Intervention Randomized Controlled Trial (DIRECT) using stored samples from 235 participants with moderate obesity randomly assigned to low-fat, restricted-calorie (n=85), Mediterranean, restricted-calorie (n=76), or low-carbohydrate, non-restricted-calorie (n=74) diets. We examined SU changes at 6- and 24-months overall, and among those with hyperuricemia (SU³416 μmol/L), a relevant subgroup at risk for gout.</p> <p>Results: Among all participants, average SU decreases were 48 μmol/L at 6-months and 18 μmol/L at 24-months, with no differences between diets (p>0.05). Body weight, HDL-C, total cholesterol to HDL-C ratio, triglycerides, and insulin concentrations also improved in all three groups (p<0.05 at 6 months). Adjusting for covariates, changes in weight and fasting plasma insulin concentrations remained associated with SU changes (p<0.05). SU reductions among those with hyperuricemia were 113, 119, and 143 μmol/L at 6 months for low-fat, Mediterranean, and low-carbohydrate diets (all p for within-group comparison <0.001; p>0.05 for between-group comparisons), and 65, 77, and 83 μmol/L, respectively, at 24-months (all p for within-group comparison <0.01; p>0.05 for between-group comparisons).</p> <a>Conclusions</a>: <a>Non-purine-focused weight loss diets may simultaneously improve SU and cardiovascular risk factors, likely mediated by reducing adiposity and insulin resistance. </a>These dietary options could provide personalized pathways to suit patient comorbidity and preferences for adherence.


Obesity ◽  
2017 ◽  
Vol 25 (10) ◽  
pp. 1682-1690 ◽  
Author(s):  
Brenda Burgess ◽  
Hollie A. Raynor ◽  
Beverly J. Tepper

Sign in / Sign up

Export Citation Format

Share Document